Some scientific publications also consider DSIP as a co-regulator of other neurohormonal systems, including somatotropin, prolactin, and ACTH, especially in the context of adaptation to physical exertion, overtraining, and chronic stress
Sources Novo Nordisk NDA filing for CagriSema, December 18, 2025 American Diabetes Association REDEFINE-1 and REDEFINE-2 results, ADA 2026 Scientific Sessions HCPLive REDEFINE-1 Phase 3 safety and efficacy data Clinical Trials Arena REDEFINE-4: CagriSema vs tirzepatide head-to-head, February 2026 Life Science Daily News CagriSema FDA review timeline and NDA update, July 2026 PharmExec REDEFINE-1 results: CagriSema falls short of 25% weight loss target Drugs.com CagriSema FDA approval status history New England Journal of Medicine REDEFINE-1 full publication (presented at ADA 2026) Novo Nordisk REIMAGINE Phase 3 diabetes trial results, ADA 2026 and The Lancet FDA Wegovy (semaglutide) prescribing information, 2025 Related reading on Heally: What is Wegovy HD
The BI & Lilly Alliance has had no control or input into the educational content of this programme, choice of speakers, nor the opportunity to influence presentations
PURITY TESTING: PRODUCT Ipamorelin 10mg from Pure Tested Peptides BATCH ID 20250808 TESTED BY Krause Analytical on 25 Nov 2025 VERIFICATION Link PLEASE NOTE THAT ALL PRODUCTS FEATURED HERE ARE INTENDED EXCLUSIVELY FOR RESEARCH AND DEVELOPMENT PURPOSES
